Janet Gunzer-Toste

Title: Janet Gunzer-Toste: Innovator in Pharmaceutical Compounds

Introduction

Janet Gunzer-Toste is a notable inventor based in South San Francisco, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target lipid kinases. Her work is crucial for advancing treatments for various disorders, including cancer.

Latest Patents

Janet holds 1 patent for her innovative pharmaceutical compounds. The patent details compounds of Formulae Ia, along with their stereoisomers, geometric isomers, tautomers, solvates, metabolites, and pharmaceutically acceptable salts. These compounds are designed to inhibit lipid kinases, such as PI3K, and are useful in treating disorders mediated by these kinases. The patent also discloses methods for using these compounds in vitro, in situ, and in vivo for diagnosis, prevention, or treatment of related disorders in mammalian cells.

Career Highlights

Throughout her career, Janet has worked with prominent companies in the pharmaceutical industry. She has been associated with F. Hoffmann-La Roche AG and Genentech, Inc., where she contributed her expertise in drug development and innovation.

Collaborations

Janet has collaborated with notable colleagues, including Adrian Folkes and Sally Oxenford. These collaborations have further enhanced her research and development efforts in the pharmaceutical sector.

Conclusion

Janet Gunzer-Toste's contributions to pharmaceutical innovations highlight her role as a key inventor in the field. Her work continues to impact the treatment of serious health conditions, showcasing the importance of innovation in medicine.